"Designing Growth Strategies is in our DNA"

Viral Vector Market Size, Share & Industry Analysis, By Type, By Grade, By Application, By Therapeutic Area, By End User, and Regional Forecast, 2026-2034

Last Updated: November 20, 2026 | Format: PDF | Report ID: FBI119780

 


To get information on various segments, share your queries with us

ATTRIBUTE  DETAILS
Study Period 2021-2034
Base Year 2025
Estimated Year  2026
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 16.77% from 2026 to 2034
Unit Value (USD Billion)
Segmentation By Type, Grade, Application, Therapeutic Area, End User, and Region
By Type
  • Adeno-Associated Viral (AAV) Vectors
  • Lentiviral Vectors
  • Adenoviral Vectors
  • Gamma-Retroviral Vectors
  • Herpes Simplex Virus Vectors
  • Poxviral Vectors
  • Sendai Virus Vectors
  • Baculoviral Vectors
  • Vesicular Stomatitis Virus Vectors
  • Measles Virus Vectors
  • Others
By Grade
  • Research Grade / RUO
  • Preclinical Grade / Non-GMP
  • Clinical GMP
  • Commercial GMP
By Application
  • In-Vivo Gene Therapy
  • Ex-Vivo Cell & Gene Therapy
  • Vaccine Development
  • Oncolytic Virotherapy
  • Research & Functional Genomics
  • Others
By Therapeutic Area
  • Oncology
  • Neurological Disorders
  • Ophthalmic Disorders
  • Hematological Disorders
  • Infectious Diseases
  • Metabolic & Endocrine Disorders
  • Cardiovascular Disorders
  • Musculoskeletal Disorders
  • Others
By End User
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations
  • Government & Non-Profit Research Institutes
  • Others
By Region 
  • North America (By Type, Grade, Application, Therapeutic Area, End User, and Country)
    • U.S. 
    • Canada
  • Europe (By Type, Grade, Application, Therapeutic Area, End User, and Country/Sub-region)
    • Germany 
    • U.K.
    • France 
    • Spain 
    • Italy 
    • Scandinavia 
    • Rest of Europe
  • Asia Pacific (By Type, Grade, Application, Therapeutic Area, End User, and Country/Sub-region)
    • China 
    • Japan 
    • India 
    • Australia 
    • Southeast Asia 
    • Rest of Asia Pacific 
  • Latin America (By Type, Grade, Application, Therapeutic Area, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Grade, Application, Therapeutic Area, End User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

 

  • 2021-2034
  • 2025
  • 2021-2024
  • 190
Download Free Sample

    man icon
    Mail icon
    Mail icon

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann